
GC32054
Rovazolac
Also known as ethyl 2-[5-[4-(3-methylsulfonylphenyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]acetate
Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1
ChemicalCAS1454288-88-0MW452.45FormulaC21H19F3N2O4S
- CAS number
- 1454288-88-0
- Molecular weight
- 452.45
- Formula
- C21H19F3N2O4S
- Solubility
- Ethanol : 25 mg/mL (55·25 mM)
- InChIKey
- ZUMNJDGBYXHASJ-UHFFFAOYSA-N
- Catalogue number
- GC32054
- Brand
- GLPBIO
Computed properties PubChem CID 89792952 · XLogP 4.1 · TPSA 86.6 Ų · H-bond donors 0
- XLogP
- 4.1
- TPSA
- 86.6 Ų
- H-bond donors
- 0
- H-bond acceptors
- 8
- Rotatable bonds
- 7
- Heavy atoms
- 31
SMILES CCOC(=O)CN1C(=CC(=N1)C(F)(F)F)C2=CC=C(C=C2)C3=CC(=CC=C3)S(=O)(=O)C
Computed descriptors from PubChem (CID 89792952), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il